Micron Technology (MU.O) shares down 1.5% in pre-market trading.

Financial Times: AstraZeneca is exploring a merger with U.S. peer Bristol Myers Squibb that would create one of the world’s largest drugmakers with a combined market value near $400 bln. The companies have held talks in recent months and could reach an agreement soon, but negotiations may also be delayed or collapse. AstraZeneca’s market cap is about £196 bln; Bristol Myers Squibb’s is about $133 bln. The transaction would further accelerate AstraZeneca’s strategic shift toward the U.S. market.

A股核電概念持續走強，盈峯環境、利柏特雙雙漲停，常輔股份、瑞迪智驅漲超10%，立航科技、哈焊華通、天力複合、金利華電等跟漲。